Vimpat 200 MG/20 ML vial 20ML
Ended Awarded
- Contract number
- SPE2DB25FJW79
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,365
Award facts
- Contract value 100% obligated
- $1,365.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of VIMPAT 200 mg/20 ml vials valued at $1,365.00. This is a firm fixed-price delivery order with an ultimate completion date of September 12, 2025, and represents a non-competitive set-aside award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime vehicle running through December 2026 that supports pharmaceutical procurement for military healthcare systems globally.
VIMPAT (lacosamide) is an anticonvulsant medication used for seizure management and neuropathic pain treatment, reflecting the breadth of pharmaceutical products AmerisourceBergen supplies through its federal contract portfolio. The delivery order demonstrates AmerisourceBergen's continued role as a critical vendor for the Defense Logistics Agency's medical supply chain, supporting the Defense Health Agency and other federal healthcare systems. As a child award under the larger SPE2DX vehicle, this order contributes to the company's comprehensive support of military medical operations while competing within the federal pharmaceutical procurement marketplace.
Quick answers
Who was awarded contract SPE2DB25FJW79?
SPE2DB25FJW79 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 11, 2025.
How much is contract SPE2DB25FJW79 worth?
The government has obligated $1,365 on SPE2DB25FJW79.
Is contract SPE2DB25FJW79 an order under another contract?
Yes. SPE2DB25FJW79 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB25FJW79 competed?
The extent of competition for SPE2DB25FJW79 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award